Department of Cell Biology, University of Miami, Miller School of Medicine, Miami, Florida.
Institute for Bioethics and Health Policy, University of Miami, Miller School of Medicine, Miami, Florida.
Anat Sci Educ. 2019 May;12(3):317-325. doi: 10.1002/ase.1809. Epub 2018 Sep 21.
With the ongoing and expanding use of willed bodies in medical education and research, there has been a concomitant rise in the need for willed bodies and an increase in the means of supplying these bodies. A relatively recent development to enlarge this supply has been the growth of for- profit willed body companies ("body brokers") in the United States. These companies advertise for donors, cover all cremation and other fees for the donor, distribute the bodies or body parts nationally and internationally, and charge their users for access to the body or body parts. In doing so, they generate substantial profits. This review examines the historical development of willed body programs, the legal and economic aspects of willed body programs, and then provides an ethical framework for the use of willed bodies. The ethical principles described include detailed informed consent from the donors, comprehensive and transparent information about the process from the body donation organizations, and societal input on the proper and legal handling of willed bodies. Based on the ethical principles outlined, it is recommended that there be no commercialization or commodification of willed bodies, and that programs that use willed bodies should not generate profit.
随着意愿供体在医学教育和研究中的持续和不断扩大的应用,对意愿供体的需求也相应增加,提供这些供体的手段也有所增加。最近一个扩大这种供应的新举措是美国营利性意愿体公司(“遗体经纪人”)的发展。这些公司为捐赠者做广告,支付捐赠者的所有火化和其他费用,在国内外分配尸体或身体部位,并向使用者收取使用尸体或身体部位的费用。这样一来,他们获得了巨额利润。本文回顾了意愿体项目的历史发展,意愿体项目的法律和经济方面,然后为意愿体的使用提供了一个伦理框架。所描述的伦理原则包括来自捐赠者的详细知情同意,来自遗体捐赠组织的关于该过程的全面和透明信息,以及社会对意愿体的适当和合法处理的意见。根据概述的伦理原则,建议不要将意愿体商业化或商品化,使用意愿体的项目也不应产生利润。